Florida Region

1-888-TENET4U

5810 Coral Ridge Drive, Suite 300 Coral Springs, Florida 33076

About Us

Clinical Trials

Scientist using a pipetteOur doctors and nurses use advanced procedures and modern equipment to provide you with high-quality care. If, however, your condition leads us into unresolved areas of medical science we’ll discuss with you the option of participating in a clinical trial. Sometimes, your doctor and specialists will decide on certain clinical trials that are your best option. In those cases, we’ll work hard to get you enrolled in those trials.

We not only strive to administer the best medicine available today, but also work to further medicine for tomorrow. We strive to be leaders in clinical research, exploring advancements in medical treatments and medications for the benefit of our patients and our community. But more importantly, we will use every possible option to help you return to a full life.

Clinical trials at Delray Medical Center

BHR-100/SyNAPSE, Progesterone in Traumatic Brain Injury Study
Delray Medical Center, 2012; study completed
Principal Investigator

SyNAPSe – Phase 3 Study of the Neuroprotective Activity of Progesterone in Severe Traumatic Brain Injuries
Principal Investigator: Lloyd Zucker, MD
Completed

ProTECT III Progesterone for the Treatment of Traumatic Brain Injury
Supported by: National Institute for Neurological Disorders and Stroke
Principal Investigator: Lloyd Zucker, MD
Completed

The Safety of Autologous Human Schwann Cells (ahSC) in Subjects with Suloacute Spinal Cord Injury (SCI)
Supported by: University of Miami, The Miami Project to Cure Paralysis
Delray site: Principal Investigator: Lloyd Zucker, MD
Active

Phase III RE-VERSE-AD a study of the Reversal Effects of ldarucizumab on Active
Dabigatran Trial

Active
Principal Investigator: Nils Mueller- Kronast, MD
Sub-Investigator: Lloyd Zucker, MD

NETT Neurological Emergencies Treatment Trial Networks Participant

MiSPACE Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Principal Investigator: Lloyd Zucker, MD
Active

Phase III Clinical Trial Evaluating DCVax-L, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme
Pending
Principal Investigator: Lloyd Zucker, MD

For more information on Clinical Trials, click here

Stay Connected

Join us on Facebook

Watch us on YouTube

Follow us on Twitter